Keratoconus: The Eye Condition That Distorts Vision as Corneas Thin and Cone

Clear vision depends on the cornea — the transparent dome at the front of the eye — maintaining a smooth, regular curvature. When the cornea thins and begins to bulge outward into a cone shape, light entering the eye scatters rather than focusing cleanly on the retina. The result is progressive, increasingly distorted vision that spectacles can no longer fully correct.

This is keratoconus — a structural eye condition that typically begins in adolescence or early adulthood and progresses through the most educationally and professionally important decades of a person’s life. It is more common than many people realise, more treatable than it once was, and more consequential when left unmanaged than its quiet onset suggests.

What Is Keratoconus?

Keratoconus is a progressive eye condition in which the cornea — normally dome-shaped and stable — gradually thins and bulges forward into a cone-like shape. This structural change, called ectasia, distorts the way light passes through the cornea and focuses on the retina, producing blurred, distorted, and ghosted vision that worsens over time.

The Role of the Cornea in Vision

The cornea contributes approximately 70% of the eye’s total focusing power. Its smooth, regular curvature bends incoming light precisely onto the retina, enabling sharp vision. When keratoconus distorts the corneal shape, this focusing mechanism breaks down. Regular spectacles correct simple refractive errors — short-sightedness, long-sightedness, regular astigmatism — but cannot adequately compensate for the irregular astigmatism that keratoconus produces.

As the cornea progressively steepens and thins, even the best spectacle correction leaves vision blurry and distorted. People with advanced keratoconus often describe seeing multiple ghost images, halos around lights, streaking from bright sources, and significant difficulty with night vision.

When Keratoconus Was First Described

Keratoconus has been recognised as a distinct clinical entity for over two centuries. John Nottingham first clearly described the condition in 1854. Since then, clinical understanding has evolved from recognition to precise mapping of the corneal changes involved, and from observation to a range of interventions that can halt progression and restore functional vision.

Modern corneal topography and tomography have transformed understanding of keratoconus. These technologies map the curvature and thickness of the entire corneal surface in three dimensions, detecting keratoconus at stages far earlier than clinical examination alone could achieve.

How Common Is Keratoconus?

The true prevalence of keratoconus has been progressively revised upward as diagnostic technology has improved. Early estimates placed prevalence at approximately 1 in 2,000. More recent population studies using advanced corneal tomography suggest prevalence may be considerably higher — some estimates approaching 1 in 375 people.

Age of Onset and Progression Patterns

Keratoconus typically begins during puberty or adolescence and progresses through the twenties and thirties. Progression tends to slow or stabilise by the fourth or fifth decade of life, though this varies considerably between individuals. Some people experience rapid, early progression that threatens functional vision within years of onset. Others progress slowly over decades.

This variability makes identifying who will progress rapidly versus slowly a key challenge in keratoconus management. Early identification and monitoring allow timely intervention at the critical point when progression is detected but before vision loss becomes significant.

Gender and Ethnic Variations

Keratoconus affects people across all genders and ethnic backgrounds. Some research suggests slightly higher prevalence in males, though gender differences are modest and may reflect referral bias. More consistently, research demonstrates higher prevalence and more severe disease in people of South Asian and Middle Eastern heritage compared to European populations.

Studies conducted in the United Kingdom, New Zealand, and the Middle East consistently show two to four times higher keratoconus prevalence in South Asian communities. This elevated prevalence likely reflects a combination of genetic predisposition and environmental factors including eye rubbing behaviour and allergy prevalence.

Causes and Risk Factors for Keratoconus

Keratoconus develops from a combination of genetic predisposition, biomechanical corneal vulnerability, and environmental triggers. Understanding these contributing factors informs both risk assessment and preventive strategies.

Genetic Contributions

Keratoconus runs in families. Approximately 10% of people with keratoconus have a first-degree relative with the condition. Multiple genes influencing collagen structure, corneal biomechanics, and inflammatory pathways have been associated with keratoconus susceptibility. However, no single gene determines keratoconus development — the genetic architecture is complex and polygenic.

Keratoconus also associates with several systemic genetic conditions. Down syndrome carries a significantly elevated keratoconus prevalence of approximately 15% to 30%. Connective tissue disorders including Marfan syndrome and Ehlers-Danlos syndrome also associate with keratoconus, reflecting their shared collagen structural vulnerability.

The Critical Role of Eye Rubbing

Chronic, vigorous eye rubbing is one of the most significant modifiable risk factors for keratoconus onset and progression. Eye rubbing generates mechanical stress on the cornea that damages collagen fibres, triggers inflammatory mediator release, and may physically distort corneal shape over time.

Eye rubbing is particularly common in people with allergic eye disease — atopic keratoconjunctivitis, vernal keratoconjunctivitis, and hay fever-related ocular symptoms all drive the rubbing reflex. The association between atopy, eye rubbing, and keratoconus is well-established in the clinical literature.

Stopping eye rubbing — and treating the underlying allergic eye disease driving the urge to rub — is one of the most important interventions in keratoconus management. This advice must be delivered clearly, repeatedly, and with practical guidance on managing the allergic itch that drives the behaviour.

Contact Lens Wear and Corneal Biomechanics

Long-term hard contact lens wear has historically been associated with keratoconus. The relationship is complex — contact lenses can mask early keratoconus by temporarily regularising the corneal surface, and ill-fitting lenses may exacerbate corneal stress. Modern research suggests that contact lenses do not cause keratoconus but may worsen progression in predisposed individuals through chronic mechanical trauma.

Corneal biomechanical measurements — assessing the cornea’s stiffness and elastic behaviour rather than just its shape — provide additional information about keratoconus risk and progression likelihood. The Corvis ST and Ocular Response Analyzer measure corneal hysteresis and other biomechanical parameters that complement topographic assessment in identifying eyes at risk.

Recognising Keratoconus: Symptoms and Signs

Keratoconus typically begins with subtle visual changes that people initially attribute to a worsening spectacle prescription. Understanding its characteristic symptom pattern helps clinicians and individuals recognise it earlier.

Early Symptoms

The earliest symptoms of keratoconus are often mild and non-specific. Progressive blurring of vision despite a recently updated spectacle prescription is a common early presentation. Increasing sensitivity to glare and difficulty with night vision — particularly around streetlights and car headlights — also feature prominently in early keratoconus.

People may notice that vision fluctuates, being clearer at some times than others. Monocular diplopia — seeing a double or ghost image with one eye — arises from the irregular astigmatism keratoconus produces. These symptoms often prompt spectacle prescription changes without recognition of the underlying corneal condition driving them.

Progressive Visual Distortion

As keratoconus advances, visual distortion becomes more pronounced and less correctable with spectacles. Halos, streaking around lights, and multiple ghost images worsen. Spectacle correction that provided reasonable vision in earlier disease stages progressively fails to achieve adequate vision.

At this stage, many people find rigid contact lenses necessary to achieve functional vision. The rigid lens vaults over the irregular corneal surface, creating a smooth optical interface that spectacle lenses cannot provide. This is often the point at which an accurate keratoconus diagnosis is made, sometimes years after symptoms first began.

Clinical Signs on Examination

A skilled clinician examining the eyes of someone with keratoconus finds several characteristic signs. Vogt’s striae are fine stress lines visible in the deep corneal stroma on slit-lamp examination. Fleischer’s ring is an iron deposit forming a partial or complete ring at the base of the cone, visible with cobalt blue light illumination.

In more advanced keratoconus, the cone is visible to direct inspection as a forward bulging of the lower cornea. Munson’s sign describes the V-shaped indentation of the lower eyelid produced by the cone when the person looks downward. These clinical signs, combined with topographic findings, establish the keratoconus diagnosis.

Diagnosing Keratoconus

Accurate keratoconus diagnosis requires specialised corneal imaging technology beyond standard visual acuity testing or routine slit-lamp examination. Modern diagnostic platforms detect keratoconus at subclinical stages before symptoms or clinical signs appear.

Corneal Topography

Corneal topography maps the curvature of the corneal surface, producing colour-coded maps that reveal steepening, asymmetry, and the characteristic inferior cone pattern of keratoconus. Placido disc-based topographers — the most widely used technology — reflect concentric rings onto the corneal surface and analyse their distortion to calculate curvature across thousands of data points.

Keratoconus produces characteristic topographic patterns including inferior steepening, asymmetric bowtie astigmatism with skewed radial axis, and progressive increase in corneal power. These patterns are recognisable to experienced corneal specialists and form the basis of topographic keratoconus grading systems such as the Amsler-Krumeich classification.

Corneal Tomography

Corneal tomography — provided by systems such as the Pentacam and Galilei — extends beyond surface curvature mapping to provide full three-dimensional analysis of the entire cornea, including posterior corneal surface elevation and pachymetric mapping of corneal thickness at every point.

Posterior corneal surface changes often appear before anterior surface changes become detectable, making tomography particularly valuable for early keratoconus detection. Pachymetric mapping reveals the progressive corneal thinning that characterises keratoconus, with the thinnest point typically located inferiorly and nasally rather than at the geometric centre of the cornea.

Detecting Subclinical Keratoconus

Subclinical keratoconus — also called forme fruste keratoconus — refers to cases where corneal changes indicative of keratoconus are present on imaging but visual symptoms and clinical signs are absent or minimal. Detecting subclinical keratoconus is critically important in people being evaluated for laser refractive surgery.

Performing LASIK or PRK on a cornea with subclinical keratoconus risks precipitating rapid, devastating progression — a condition called post-refractive surgery ectasia. Comprehensive pre-operative corneal screening with topography and tomography is therefore mandatory before any corneal refractive procedure, specifically to exclude keratoconus and subclinical ectatic risk.

Treating Keratoconus: Halting Progression

The most significant advance in keratoconus management over the past two decades is the development of corneal collagen crosslinking — a treatment that halts progression rather than simply managing its consequences.

Corneal Collagen Crosslinking

Corneal collagen crosslinking, known as CXL or C3-R, uses ultraviolet-A light combined with riboflavin eye drops to create new bonds between the collagen fibres in the corneal stroma. These additional bonds stiffen the cornea, significantly increasing its biomechanical strength and halting the progressive thinning and steepening that characterises keratoconus.

The Dresden protocol — the original and most extensively validated CXL approach — involves removing the corneal epithelium, applying riboflavin drops for 30 minutes, then exposing the cornea to UV-A light for a further 30 minutes. This epithelium-off approach achieves the deepest riboflavin penetration and most robust crosslinking effect.

Evidence for Crosslinking Effectiveness

Multiple randomised controlled trials and long-term follow-up studies confirm that CXL halts keratoconus progression in the vast majority of treated eyes. The Cochrane review of CXL trials demonstrates consistent evidence of progression halting, with some studies showing modest improvement in corneal topographic measurements over time.

CXL does not reverse existing vision loss or corneal shape distortion in most cases. Its primary role is preventive — halting the progressive worsening that untreated keratoconus produces. For this reason, earlier treatment — before significant steepening or thinning has occurred — produces better long-term visual outcomes than treating advanced disease.

Accelerated Crosslinking Protocols

Accelerated CXL protocols use higher UV-A irradiance delivered over shorter time periods to achieve the same total UV dose as the standard Dresden protocol. These approaches reduce treatment time significantly — from approximately 60 minutes to 10 minutes or less — improving patient experience and clinical throughput.

Evidence from comparative trials suggests that accelerated protocols achieve equivalent crosslinking efficacy to the standard protocol within certain irradiance parameters, though debate continues about optimal protocols for specific clinical situations. Many specialist centres now offer accelerated CXL as their standard approach.

Treating Keratoconus: Restoring Vision

Halting progression addresses the underlying disease process. Restoring the functional vision that keratoconus has already compromised requires separate optical management strategies tailored to the degree of corneal distortion.

Spectacles in Early Keratoconus

In early keratoconus, spectacles may provide adequate vision correction. However, the irregular astigmatism that keratoconus produces limits how effectively spectacle lenses can achieve clear sight. As the condition progresses, spectacle-corrected vision typically deteriorates to the point where contact lenses become necessary for functional vision.

Regular prescription reviews are essential in progressive keratoconus, as the prescription can change significantly between appointments. Spectacle prescription changes in young people — particularly increasing astigmatism with an oblique axis — should always prompt consideration of keratoconus screening.

Rigid Gas-Permeable Contact Lenses

Rigid gas-permeable contact lenses, often called RGP or GP lenses, vault over the irregular corneal surface and create a smooth, regular optical interface between their back surface and the tear film that fills the space between the lens and the cornea. This neutralises the irregular astigmatism of keratoconus and provides significantly better vision than spectacles in most people with moderate to advanced disease.

RGP lens fitting for keratoconus requires specialist expertise. The fitting process is more complex than for normal corneas, requiring careful matching of lens geometry to the individual cone shape to achieve comfort, centration, and adequate corneal clearance. Multiple trial fittings are typically necessary before an optimal lens is achieved.

Scleral Contact Lenses

Scleral lenses are large-diameter rigid lenses that vault entirely over the cornea and rest on the less sensitive white of the eye — the sclera — rather than on the corneal surface. This design provides exceptional comfort compared to corneal RGP lenses while delivering equivalent or superior optical performance.

Scleral lenses are particularly valuable for people with advanced keratoconus, irregular cone shapes, corneal scarring, or those who find corneal RGP lenses uncomfortable. The fluid reservoir between the lens and the cornea also benefits people with associated dry eye disease, making scleral lenses increasingly the preferred contact lens modality for complex keratoconus presentations.

Hybrid Contact Lenses

Hybrid contact lenses combine a rigid central optical zone with a soft skirt. This design offers the optical clarity of a rigid lens with the comfort of a soft lens. Hybrid lenses suit people who find corneal RGP lenses uncomfortable but require better vision than soft lenses provide.

Fitting hybrid lenses for keratoconus requires careful parameter selection. The rigid central zone must adequately cover the cone apex, and the soft skirt must fit the peripheral cornea and limbal region comfortably without causing compression or restriction of lens movement.

Surgical Options for Advanced Keratoconus

When contact lens management no longer achieves functional vision — or when corneal scarring makes optical correction inadequate — surgical options become necessary. Several procedures address different aspects of advanced keratoconus.

Intracorneal Ring Segments

Intracorneal ring segments, known as ICRS or by brand names such as Intacs and Ferrara rings, are small arc-shaped plastic implants inserted into the corneal stroma to flatten and regularise the corneal shape. By redistributing corneal tissue, ring segments reduce irregular astigmatism, improve contact lens tolerance, and — in some cases — significantly improve spectacle-corrected vision.

Ring segment implantation does not halt keratoconus progression. It is therefore most effective when combined with corneal crosslinking, which stabilises the cornea before or after ring segment implantation. The combination approach addresses both the progression mechanism and the optical consequence of existing distortion.

Corneal Transplantation

Corneal transplantation — historically the treatment of last resort for keratoconus — replaces the distorted, scarred corneal tissue with donor corneal tissue. Two main transplant approaches are used in keratoconus.

Penetrating keratoplasty replaces the full thickness of the cornea. Deep anterior lamellar keratoplasty, known as DALK, replaces only the stromal layers while preserving the patient’s own endothelium — the inner cellular layer — reducing the risk of endothelial rejection and improving long-term graft survival compared to penetrating keratoplasty.

DALK has become the preferred transplant approach for keratoconus in many specialist centres worldwide, offering excellent long-term outcomes and eliminating the risk of the most serious transplant rejection response. Visual recovery after transplantation is gradual, typically taking 12 to 24 months to stabilise.

Living with Keratoconus

Keratoconus is a lifelong condition requiring ongoing monitoring, contact lens management, and adaptation. Understanding how to live well with the condition significantly improves quality of life and long-term visual outcomes.

Stopping Eye Rubbing

Stopping eye rubbing is the single most important behavioural change for people with keratoconus. Every episode of vigorous eye rubbing generates mechanical stress on an already structurally vulnerable cornea and may accelerate progression. People must understand this connection clearly and act on it consistently.

Managing the underlying allergic eye disease that drives eye rubbing is equally important. Antihistamine eye drops, mast cell stabilisers, and cold compress application all reduce the allergic itch that provokes rubbing. For people with significant atopic disease, referral to an allergy specialist may form an important part of keratoconus management.

Monitoring and Follow-Up

People with keratoconus require regular corneal topography and tomography to detect progression and time treatment appropriately. During active progression — typically in adolescence and early adulthood — six-monthly monitoring is appropriate. Stable disease in older adults may need only annual assessment.

CXL treatment does not eliminate the need for ongoing monitoring. Treated eyes require post-operative topographic assessment to confirm progression stabilisation and detect the rare cases of CXL treatment failure requiring retreatment.

Emotional Wellbeing and Support

Keratoconus affects vision during the years when education, career development, and social life are at their most intense. Anxiety about vision loss, frustration with contact lens management, and concerns about long-term prognosis are entirely understandable emotional responses that deserve clinical acknowledgment.

The National Keratoconus Foundation and KC Global provide peer support communities, educational resources, and practical guidance for people at all stages of the condition. Connecting with others who understand the daily realities of keratoconus management reduces isolation and builds informed self-advocacy.

Frequently Asked Questions

Does keratoconus always get worse over time?

Keratoconus does not always progress continuously. Many people experience a period of active progression during adolescence and early adulthood, after which the condition stabilises naturally — typically by the fourth or fifth decade of life. However, the timing and extent of spontaneous stabilisation are unpredictable. Corneal crosslinking provides reliable, treatment-induced stabilisation that does not depend on waiting for natural stability to occur. For this reason, early crosslinking in young people with documented progression is the standard of care in most specialist centres.

Can keratoconus cause complete blindness?

Keratoconus very rarely causes total blindness. The condition affects central vision quality through progressive distortion and corneal scarring rather than through the mechanism of complete light perception loss. Most people with keratoconus — even advanced cases — retain peripheral vision and some degree of central vision throughout their lives. With appropriate contact lens management and surgical intervention when indicated, the majority of people with keratoconus maintain functional vision sufficient for most daily activities.

Is LASIK safe for people with keratoconus?

No. LASIK and most other laser refractive surgery procedures are contraindicated in people with keratoconus or subclinical keratoconus. These procedures thin the cornea, which in a keratoconic eye can precipitate rapid, severe ectasia progression — a devastating complication that can be extremely difficult to manage. Comprehensive pre-operative corneal screening specifically to exclude keratoconus is mandatory before any refractive procedure. People with keratoconus seeking spectacle independence should discuss alternatives such as phakic intraocular lenses with their corneal specialist.

At what age should children be screened for keratoconus?

Children with risk factors for keratoconus — family history, Down syndrome, atopic eye disease, or vigorous eye rubbing — benefit from corneal topography screening from around age ten onwards, as keratoconus can begin during early adolescence. Routine keratoconus screening is not currently recommended for all children. However, any child with increasing myopia or astigmatism, frequent prescription changes, or reduced best-corrected visual acuity should receive corneal topography to exclude keratoconus before spectacle or contact lens management proceeds.

How successful is corneal crosslinking?

Corneal crosslinking successfully halts keratoconus progression in approximately 90% to 95% of treated eyes in studies with adequate follow-up. A small proportion of eyes — approximately 5% to 10% — continue to progress after crosslinking and may require retreatment. Success rates are highest when crosslinking is performed early in the disease course, before significant corneal thinning or steepening has occurred. In addition to halting progression, some eyes show modest improvement in corneal topographic measurements over the years following crosslinking.

Can keratoconus affect both eyes?

Yes, keratoconus affects both eyes in the vast majority of cases — research suggests over 90% of people with keratoconus eventually have bilateral involvement. However, the condition frequently presents asymmetrically, with one eye significantly more advanced than the other. This asymmetry means that monitoring both eyes is always essential, even when one eye appears entirely normal clinically. The less affected eye often develops detectable changes on topography before clinical symptoms appear.

Conclusion

Keratoconus begins quietly — a slightly worsening spectacle prescription, a touch more glare than before, a ghost image that glasses can no longer clear. These subtle early changes conceal a progressive structural process that, left undetected and untreated, can significantly compromise vision through the most productive decades of life.

The story of keratoconus management has changed profoundly in recent years. Corneal crosslinking now offers reliable, evidence-based progression halting for a condition that once progressed inevitably until transplantation became necessary. Advanced contact lens designs — particularly scleral lenses — restore excellent visual function in most people with significant corneal distortion. When surgery is needed, DALK offers excellent long-term outcomes with reduced rejection risk.

Early detection remains the key that unlocks the best possible outcomes. Recognising keratoconus at its earliest stages — through vigilance for changing prescriptions in young people, mandatory pre-refractive surgery screening, and awareness of risk factors — allows intervention before significant vision compromise occurs. Keratoconus is a lifelong condition, but with modern management, it is one that most people can live with while maintaining vision that supports a full, active, and independent life.

References

1. Graves’ Disease causes multiple symptoms from thyroid hormone excess and immune attack on multiple tissues. 
2. Diabetes affects almost every system in the body, but its impact on the eyes carries a particular cruelty. 

Disclaimer:

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis, treatment, or any eye health concerns.